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Summary: The enzymatic determination of sialic acid, commercially introduced recently äs an end point
method, has been considerably improved by the development of initial rate and peak rate modifications of
the kinetic method, respectively, and adapted to a centrifugal analyser (Cobas Bio). The assay is completed
within 3 min, takes 3 sample volume and is reduced to a total reaction volume of 153 . The costs per
test thereby are lowered to about 10% of the original procedure. Within-run and day-to-day imprecisions
(x = 0.81 g/l) are 2% and 3.9%, respectively; inaccuracy is between + 1% and —2%. The detection limit
is 0.012 g/l, i. e. about 3 times higher than that of the thiobarbituric acid method (0.0037 g/l) for sialic acid
determination. The enzymatic-kinetic assay correlates well with the latter method (r = 0.973). There was no
measurable interference by EDTA (< 3 mg/1), bilirubin (< 160 / ), haemolysis (haemoglobin < 5.25
g/l), or triglycerides (< 3.50 g/l). The reference ränge (2.5th to 97.5th percentile) for sialic acid in sera of
i! adults is 0.51 to 0.84 g/l (median 0.63 g/l) with no significant sex-related differences. The reference ränge for
» sialic acid in spontaneous urine samples is 0.01 —0.13 g/l.
;« * '
Evaluierung einer voll mechanisierten enzymatisch-kinetischen Methode der Sialinsäurebestimmung
Zusammenfassung: Eine kürzlich kommerziell eingeführte enzymatische Endpunktbestimmung der Sialin-
säure wurde deutlich verbessert durch Entwicklung von initial rate und peak rate Modifikationen der
kinetischen Bestimmung, die an einen Zentrifugalanalysator (Cobas Bio) adaptiert wurden. Die Bestimmung
ist innerhalb von 3 Minuten beendigt, benötigt ein Probevolumen von 3 und ist auf ein Gesamtvolumen
von 153 reduziert worden. Dadurch wurden die Kosten pro Test auf etwa 10% der ursprünglichen Kosten
gesenkt. Die intraserielle und interserielle Unpräzision (x = 0,81 g/l) ist 2% bzw. 3,9%, die Unrichtigkeit
| bewegt -sich zwischen +1% und —2%. Die Nachweisgrenze wurde mit 0,012 g/l bestimmt und ist somit
} etwa 3fach höher als die der Thiobarbitursäufe-Methode (0,0037 g/l) der Sialinsäurebestimmung. Die
enzymatisch-kinetische Methode korreliert gut mit der Thiöbarbitursäure-Methode (r = 0,973). EDTA (< 3
mg/1), Bilirubin (< 160 / ), Hämolyse (Hämoglobin < 5,25 g/l) und Triglyceride (< 3,50 g/l) sind keine
Störfaktoren der enzyniatischen Methode. Der Referenzbereich (2,5. — 97,5. Perzentile) der Sialinsäurekon-
zentration in Sera von Erwachsenen liegt zwischen 0,51 und 0,84 g/l (Median 0,63 g/l) ohne geschlechtsabhän-
• gige Unterschiede zu zeigen. In Spontanurinproben beträgt der diesbezügliche Referenzbereich für Sialinsäure
0,01-0,13 g/l.
Intf oduction terminal position of the oligosaccharide chains, which
Sialic acid (N-acetylneuraminic acid, NANA) is a has been shown to be crucial for their half life time
main constituent of*a large variety of glycoproteins in the circulation (l, 2). The level of protein- and
and glycolipids, and äs such it is present intracellu- lipid-bound sialic acid is regulated by the catalytic
larly, on the external cell surface and in various body activities of sialyltransferase and neuraminidase, re-
fluids. Plasma glycoproteins bear sialic acid in the spectively. Apart from rare hereditary disorders of
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sialic acid metabolism (e. g. sialidosis) (3 —5) a num-
ber of acquired diseases such s acute inflammatory
processes and tumours are associated with elevated
levels of sialic acid in serum and urine (6 — 10). In
fact, the determination of sialic acid in serum has
been proposed s a useful cancer screen; serial deter-
minations of sialic acid in patiehts with tumours
might be a reliable marker of tumour activity, pro-
gression and/or metastasis (10 — 12). Chemical meth-
ods for the measurement of sialic acid like the thio-
barbituric acid method (13), periodate resorcinol pro-
cedure (14), resorcinol-hydrochloric acid method
(15), and the method using Ehrliches reagent (10) are
either time-consuming and laborious or unreliable
due to non-specific colour interferences. Attempts
have been made for automation of sialic acid meas-
urements based on some of these reaction principles
(16, 17). Recently, highly specific enzymatic assays
of sialic acid applying neuraminidase and NANA-
aldolase have been developed and commercially in-
troduced (18,Λ19). In the present study we report a
kinetic, fully mechanized modification of a commer-
cially available test which enables fast, simple, precise,
and relative inexpensive determinations of sialic acid
in microvolumes of various body fluids and, thus, is
suitable for routine laboratory use.
Materials and Methods
Specimens
Sera, urine, cerebrospinal fluid and ascites were obtained from
the routine ciinical-chemical analysis program of the central
laboratory. Biochemically and clinically healthy blood donors
(52 females, 74 males) ranging from 19 to 48 years served s
the reference population. The specimens were stored for a
maximum of one week at —20 °C before use.
Enzymatic assay of sialic acid
Sialic acid was determined by a modification of the enzymatic
end point method introduced recently (B ehringer Mannheim
GmbH, FRG). In principle, bpund sialic acid is enzymatically
(neuraminidase) liberated and cleaved by NANA aldolase into
pyruvate and N-acetylmannosamine. Pyruvate then is enzymat-
ically oxidized, using pyruvate oxidase. The H2O2 formed feacts
in the presence of peroxidase with 4-aminoantipyrine and N-
ethyl-N^2-hydroxyethyl-3-toluidine to yield a red dye of which
the absorbance is measured at 550 nm. In the original instruc-
tion the test is performed in a total volunie of 3.02 ml with a
sample volume of 20 μΐ during an incubation time of about 60
min and read against a reagent blank. Calculation is based on
the parallel incubation of sialic acid Standard solution. The test
principle was modified in this study s will be described in
results and adapted to the Cobas Bio centrifugal anaiyser
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Fig. 1. Time-dependent change of absorbance at 550 nm in the
enzymatic assay of sialic acid. o — © 0.21 g/l, Δ-^-Δ
0.42 g/l, o-o 0.84 g/l, χ - χ l .68 g/l.
Thiobarbi tur ic acid assay of sialic acid
The original procedure of Warren was followed with only
minor modifications (13). The test was performed manually,
the absorbance was read at 549 nm using a Lambda UV/VIS
spectrophotometer (Perkin-Elmer). The test was calibrated with
a human serum popl of which the sialic concentration was
determined enzymatically.
Results
Time course of the reation
After a lag phase of about 80 s the absorbance at
550 nrri increases linearly up to 280 s (fig. 1). The
endpoint of the reaction is reached between 9.3 min
(at l w concentrations) and 13.3 min (at high concen-
n trations) (fig. 1). The maximum change of absorbance
per 40 s is aehieved 2.7 min aftdr starting the reaction
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(fig. 2). It is dependent on the concentration of sialic
acid s documented in figure 3. These kinetics allow
both an initial rate and a peak rate calculation of the
sialic acid concentration. The former takes 3 min and
includes 12 measurements in 10s intervals after a
preincubation period of l min. The peak rate modi-
fication needs about 2.7 min. Thus, the peak rate
method offers no advantages over the initial rate
technique, which therefore was used in the following
studies.
l
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Fig. 2. Time course of the maximum change of absorbance in
the enzymatic assay of sialic acid. Absorbance was
measured at 40s intervals. o—o 0.21 g/l; Δ — Δ 0.42
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Fig. 3. Relation between the maximum change of absorbance
and sialic acid concentration in the enzymatic assay.
Absorbance was measured at 40 s intervals.
Imprecision and inaccuracy
Within-run and day-to-day imprecisions at high and
normal concentrations of sialic acid are summarized
in table l and compared with the manual thiobarbitu-
ric acid procedure. As expected the analytical criteria
of the mechanized enzymatic-kinetic assay are much
superior to those of the Warren method. The inaccur-
acy of the enzymatic method tested at a sialic acid
concentration of 0.84 g/l was found to be between +1
and -2%.
Tab. 1. Within-run (n = 15) and day-to-day (n = 20) im-
precision of the enzymatic-kinetic and the thio-
barbituric acid method. Aliquots of pooled human sera
were kept frozen at — 20 °C. The data are given for






































Sensitivity and l ineari ty
The detection limit of the enzymatic assay is defined
at a sialic acid concentration of 0.012 g/l correspond-
ing to 36 ng in the assay, whereas that of the thiobar-
bituric acid method is 0.0037 g/l. Thus, the sensitivity
of the latter method is about 3 times higher than
that of the enzymatic procedure. The linearity of the
enzymatic method was tested up to a sialic acid
concentration of 3 g/l. Within the r nge between 3
and 0.012 g/l the measured values were proportional
to those expected from the sample dilutions.
Interference and sample stability
The enzymatic-kinetic assay of sialic acid did not
show any interferences with EDTA up to 3 mg/1, ci-
trate up to 0.015 mol/1, bilirubin up to 160 μιηοΐ/ΐ, free
haemoglobin up to 0.33 mmol/1 and triglycerides up to
4.0 mmol/1. Increasing concentrations of lipids caused
erroneously high measurements of sialic acid concen-
tration. Sample stability was tested for 3 weeks at
storage temperatures of -20 °C, + 4 °C and +22 °C.
During this period the concentration of sialic acid
was found to be unchanged at any temperature.
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Comparison between the enzymatic-kinet ic
and the thiobarbi tur ic acid method
The correlation between both methods was found to
be satisfactory (r = 0,973, y = 0.9845 χ -0.0506).
The concentrations of sialic acid ranging from 0.32
to 1.40 g/l determined in 63 unselected human sera
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Fig. 4. Statistical correlation between the enzymatic-kinetic (y)
and the thiobarbituric acid (x) method for determina-
tion of sialic acid in unselected human sera. r = 0.973,
y = 0.9845 χ -0.0506, n = 63.
Reference values
The reference ranges were determined in 74 male and
52 female healthy blood donors (ranging from 19 to
48 years) (tab. 2). The sialic acid conceiitration in
males (median 0.63 g/l) and females (median 0.61 g/l)
did not differ significaritly.
Tab. 2. Reference ranges of sialic acid concentrations in serum.
Percentile
Median 2.5th 5th 95th 97.5th
sialic
acid



















Sialic acid determinations in other body flu*
ids
The reference r nge (2.5th—97.5th percentile) of
sialic acid concentration in spontaneous urine sam-
ples (n = 30) is 0.01-0.13 g/l. In aseites from a
patient with liver cirrhosis a sialic acid concentration
of 0.06 g/l was determined, whereas in aseites due to
peritonitis carcinomatosa a substantial increase of
sialic acid (0.94 g/l) was measured. In cerebrospinal
fluids (n = 4) the concentrations ranged from 0.02 g/l
(normal composition) to 0.20 g/l (bacterial naeningitis
with a greatly elevated total cell number and total
protein concentration).
Discussion
The kinetic method of the enzymatic determination
of sialic acid proves to be a rather simple, fast, precise,
and relative inexpensive method for assaying the
sugar in various body fluids. It avpids a reagent
blank, is free of unspecific coio r interferences and,
s a further advantage, is suitable for mechanization
s demonstrated in this communication by adapta-
tion to the Cobas Bio centrifugal analyser. By these
criteria the method is superior to those developed
previously with a different reaction principle (10,
13 — 15). The determinations can be made in micfovq-
lumes of unextracted samples. The results of this
method correlate well with those of the widely used
Warren procedure (13). The sensitivity of the en-
zymatic method is lower than that of the thiobarbitu-
ric acid procedure (13) but still sufficient for most
clinical purposes. Only 4/30-of normal spontaneous
urine samples have sialic acid concentrations hardly
detectable by the enzymatic-kinetic method. Clini-
cally relevant increases in the urinary Output of sialic
acid in cases of sialidosis (3 — 5) can be monitored
sensitively with the present method. The data for the
reference r nge of sialic acid concentrations in urine
are similar to those established recently with a coin-
parable enzymatic method (19). Taken together the
procedure described here will provide the analytic
basis for large scale evaluation of the diagnostic and/
or prognostic potential of sialic acid in sera, urine
and other body fluids of patients with cancer (6—10),
acute and chronic inflammatory processes (6, 10),
and some inborn errors of sialic acid metabolisin
(3-5,19,20).
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